Takashi Toya, Kota Mizuno, Masatoshi Sakurai, Jun Kato, Takehiko Mori, Noriko Doki, Shinichi Masuda, Nobuyuki Aotsuka, Shokichi Tsukamoto, Emiko Sakaida, Yuki Nakajima, Shin Fujisawa, Shinichiro Machida, Yasuyuki Aoyama, Hiroki Yokoyama, Katsuhiro Shono, Yoshihiro Hatta, Kensuke Usuki, Keisuke Kataoka, Yoshinobu Kanda
Clinically significant cytomegalovirus infection (csCMVi) is frequently observed after allogeneic hematopoietic stem cell transplantation (HSCT) and prophylaxis with letermovir is commonly adopted. However, the clinical benefit of letermovir prophylaxis according to graft sources has not been sufficiently elucidated. We retrospectively analyzed 2,194 CMV-seropositive HSCT recipients (236 with letermovir prophylaxis and 1,958 without prophylaxis against CMV). csCMVi was significantly less frequent in patients with than in those without letermovir prophylaxis (23...
December 15, 2023: Blood Advances